PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.86%
Positive revenue growth while TSM is negative. John Neff might see a notable competitive edge here.
21.26%
Positive gross profit growth while TSM is negative. John Neff would see a clear operational edge over the competitor.
70.38%
Positive EBIT growth while TSM is negative. John Neff might see a substantial edge in operational management.
70.38%
Positive operating income growth while TSM is negative. John Neff might view this as a competitive edge in operations.
44.48%
Positive net income growth while TSM is negative. John Neff might see a big relative performance advantage.
45.61%
Positive EPS growth while TSM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
43.86%
Positive diluted EPS growth while TSM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.24%
Share count expansion well above TSM's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.52%
Diluted share count expanding well above TSM's 0.00%. Michael Burry would fear significant dilution to existing owners' stakes.
0.78%
Maintaining or increasing dividends while TSM cut them. John Neff might see a strong edge in shareholder returns.
29.44%
OCF growth above 1.5x TSM's 14.11%. David Dodd would confirm a clear edge in underlying cash generation.
53.05%
FCF growth above 1.5x TSM's 18.92%. David Dodd would verify if the firm’s strategic investments yield superior returns.
652.53%
10Y revenue/share CAGR above 1.5x TSM's 299.78%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
120.08%
5Y revenue/share CAGR at 50-75% of TSM's 170.98%. Martin Whitman would worry about a lagging mid-term growth trajectory.
132.18%
3Y revenue/share CAGR above 1.5x TSM's 63.50%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
1555.59%
10Y OCF/share CAGR above 1.5x TSM's 374.91%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
97.70%
5Y OCF/share CAGR at 50-75% of TSM's 195.10%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
218.43%
3Y OCF/share CAGR above 1.5x TSM's 97.76%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
2520.23%
Net income/share CAGR above 1.5x TSM's 371.05% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
61.17%
Below 50% of TSM's 267.28%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
121.53%
3Y net income/share CAGR above 1.5x TSM's 61.42%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
407.76%
10Y equity/share CAGR 1.25-1.5x TSM's 304.95%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
211.82%
5Y equity/share CAGR above 1.5x TSM's 108.61%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
86.13%
3Y equity/share CAGR similar to TSM's 87.51%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
113.76%
Dividend/share CAGR of 113.76% while TSM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
6.77%
Dividend/share CAGR of 6.77% while TSM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
0.45%
Below 50% of TSM's 20.01%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
6.61%
AR growth well above TSM's 0.02%. Michael Burry fears inflated revenue or higher default risk in the near future.
-10.62%
Inventory is declining while TSM stands at 6.42%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
7.96%
Asset growth above 1.5x TSM's 4.62%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
10.68%
BV/share growth above 1.5x TSM's 5.19%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
1.90%
Debt shrinking faster vs. TSM's 5.25%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-3.94%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
1.28%
We expand SG&A while TSM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.